KALA
Kala Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$101.31M
P/E Ratio
—
EPS
$-3.31
Beta
-2.24
52W High
$20.60
52W Low
$0.10
50-Day MA
$0.24
200-Day MA
$3.30
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Kala Pharmaceuticals Inc
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $1.33M |
| EBITDA | $-42.09M |
| Operating Margin | 0.00% |
| Return on Equity | -279.20% |
| Return on Assets | -81.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.25 |
| Price-to-Book | 14.48 |
| Price-to-Sales (TTM) | 23.75 |
| EV/Revenue | 0.0421 |
| EV/EBITDA | -0.16 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $929.49M |
| Float | $929.42M |
| % Insiders | 0.01% |
| % Institutions | 0.76% |
Historical Volatility
HV 10-Day
88.77%
HV 20-Day
120.38%
HV 30-Day
108.98%
HV 60-Day
125.93%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/5/2026